Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents-Reference-Cited by-同舟云学术

Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents

Published:2021-12 Issue:3 Volume:1 Page:345-356
ISSN:2772-3747
Container-title:JACC: Asia
language:en
Short-container-title:JACC: Asia

Author:

Yoshikawa Yusuke,Shiomi Hiroki,Morimoto Takeshi,Takeji Yasuaki,Matsumura-Nakano Yukiko,Yamamoto Ko,Yamamoto Erika,Kato Eri T.,Watanabe Hirotoshi,Saito Naritatsu,Domei Takenori,Tada Takeshi,Nawada Ryuzo,Onodera Tomoya,Suwa Satoru,Tamura Toshihiro,Ishii Katsuhisa,Ando Kenji,Furukawa Yutaka,Kadota Kazushige,Nakagawa Yoshihisa,Kimura Takeshi

Publisher

Elsevier BV

Reference36 articles.

1. 2018 ESC/EACTS guidelines on myocardial revascularization;Neumann;Eur Heart J,2019

2. Stent-related adverse events >1 year after percutaneous coronary intervention;Madhavan;J Am Coll Cardiol,2020

3. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis. An analysis of 431 cases;Van Werkum;Circulation,2009

4. Stent thrombosis;Holmes;J Am Coll Cardiol,2010

5. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent long-term (5-7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2;Natsuaki;Circ Cardiovasc Interv,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients;JACC: Cardiovascular Interventions;2024-09

2. Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography;Canadian Journal of Cardiology;2023-12

3. Prolonged dual antiplatelet therapy after drug-eluting stent implantation improves long-term prognosis for acute coronary syndrome: five-year results from a large cohort study;World Journal of Emergency Medicine;2023

4. One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis;Cardiovascular Diabetology;2022-10-28